{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001074","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.280345+00:00","generated_at":"2026-05-28T10:47:26.206036+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sigyn Therapeutics reduces authorized common shares to 100M via charter amendment","bullets":["Filed Certificate of Amendment decreasing authorized common stock to 100 million shares (par value $0.0001).","Authorized preferred stock unchanged at 10 million shares (par value $0.0001).","Amendment effective upon filing on December 30, 2024.","No other changes to the Amended and Restated Certificate of Incorporation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001074","json":"https://secwatch.observer/filing/0001493152-25-001074.json","markdown":"https://secwatch.observer/filing/0001493152-25-001074.md","text":"https://secwatch.observer/filing/0001493152-25-001074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315225001074/0001493152-25-001074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315225001074/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T10:47:26.206036+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}